Facebook Linkedin RSS Twitter Youtube
Home 2024

Phase II clinical trials (Clinical trial)

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths
Cancer

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths

StockWatch: MacroGenics Shares Crater after Trial Deaths
Drug Discovery

StockWatch: MacroGenics Shares Crater after Trial Deaths

Insilico Doses First Patient with AI-Designed IBD Treatment
Artificial Intelligence

Insilico Doses First Patient with AI-Designed IBD Treatment

Immune Cell Therapy May Become More Naturalistic
Cancer

Immune Cell Therapy May Become More Naturalistic

Locks on Translation Initiation May Restrain Cancer
Cancer

Locks on Translation Initiation May Restrain Cancer

Personalized Skin Tissue Bioengineered on Demand
Insights

Personalized Skin Tissue Bioengineered on Demand

Pancreatic Tumors May Respond to Bone Marrow Cancer Drug
Cancer

Pancreatic Tumors May Respond to Bone Marrow Cancer Drug

Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease, Shows Efficacy
News

Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease, Shows Efficacy

Poxvirus Therapy: Existing Drugs May Offer New, More Durable Approach
Featured

Poxvirus Therapy: Existing Drugs May Offer New, More Durable Approach

First-in-Class Drug for Treating Cannabis Use Disorder Shows Promise in Clinical Trial
Drug Discovery

First-in-Class Drug for Treating Cannabis Use Disorder Shows Promise in Clinical Trial

123...20Page 1 of 20
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.